Home
Conditions
Neoplasms, Connective and Soft Tissue

Clinical trial condition

Neoplasms, Connective and Soft Tissue

Explore clinical trials studying Neoplasms, Connective and Soft Tissue. Study availability and eligibility vary by location and protocol.

2,726 public trials 586 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Connective and Soft Tissue trial results

Active, Not Recruiting

Effects of Simvastatin on Uterine Leiomyoma Size

NCT03400826

Conditions: Fibroid Tumor, Fibroid Uterus, Fibromyoma, +6 more
Locations: Johns Hopkins Hospital Baltimore, Maryland, United States

View Trial Details

Active, Not Recruiting

Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by Surgery

NCT02923778

Conditions: Histiocytoma, Histiocytoma, Malignant Fibrous, Leiomyosarcoma, +16 more
Locations: Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States

City of Hope Comprehensive Cancer Center Duarte, California, United States

UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States

Mayo Clinic in Florida Jacksonville, Florida, United States

View all 17 locations

View Trial Details

Active, Not Recruiting

Evaluation of a Novel CT-On-Rails or Trilogy Stereotactic Spine Radiotherapy System (SSRS)

NCT00508443

Conditions: Bone Diseases, Bone Neoplasms, Breast Diseases, +34 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

A Study of Rucaparib and Nivolumab in People With Leiomyosarcoma

NCT04624178

Conditions: Leiomyosarcoma, Neoplasms, Neoplasms by Histologic Type, +3 more
Locations: Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States

Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States

Memorial Sloan Kettering Commack (Limited protocol activities) Commack, New York, United States

View Trial Details

Active, Not Recruiting

A Study of Talimogene Laherparepvec (T-VEC) in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced Sarcoma

NCT03069378

Conditions: Cutaneous Angiosarcoma, Epithelioid Sarcoma, Neoplasm Metastasis, +7 more
Locations: Enable Medicine (Specimen Analysis Only) Menlo Park, California, United States

Stanford University Medical Center Stanford, California, United States

Memorial Sloan Kettering Westchester (Limited Protocol Activities) Harrison, New York, United States

Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Active, Not Recruiting

68Ga-FAPi-46 PET/CT Scan in Imaging Patients With Sarcoma

NCT04457258

Conditions: Metastatic Sarcoma, Neoplasms, Neoplasms by Histologic Type, +3 more
Locations: UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Active, Not Recruiting

Mocetinostat With Vinorelbine in Children, Adolescents & Young Adults With Refractory and/or Recurrent Rhabdomyosarcoma

NCT04299113

Conditions: Myosarcoma, Neoplasms, Neoplasms by Histologic Type, +4 more
Locations: Rebecca Phelan Los Angeles, California, United States

View Trial Details

Active, Not Recruiting

Neoadjuvant Intralesional Injection of Talimogene Laherparepvec

NCT06660810

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, +3 more
Locations: University of Iowa Iowa City, Iowa, United States

View Trial Details

Active, Not Recruiting

Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women

NCT06904365

Conditions: Anal Cancer, Anus Diseases, Anus Neoplasms, +56 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Active, Not Recruiting

Phase 2 Study to Evaluate the Efficacy of Regorafenib in Specific GIST Mutation Subsets (KIT Exon 17, 18, or 14 Mutation and SDHB Deficient GIST) in the Post-imatinib Second-line Setting.

NCT06087263

Conditions: Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +6 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Neoplasms, Connective and Soft Tissue

Neoplasms, Connective and Soft Tissue trial results

Related conditions